Metabolic disorders: Such as phenylketonuria (PKU), galactosemia, and amino acid metabolism defects. Enzyme deficiencies: Including deficiencies of specific enzymes that affect how the body processes nutrients. Other disorders: May include some rare genetic conditions that can impact a child’s growth and development.

All newborns: This test is performed as part of routine screening for all newborn babies after birth. Children with a family history of genetic disorders: It is recommended for children who have relatives with known genetic conditions. Children born under special medical conditions: Such as babies born with low birth weight or those who underwent blood transfusions. Children showing abnormal symptoms: Such as poor growth or feeding difficulties.

Growth delay: Failure to gain weight or grow in length normally. Feeding problems: Difficulty breastfeeding or decreased appetite. Behavioral changes: Such as lethargy or noticeably low activity. Breathing difficulties: Such as labored or rapid breathing. Skin disorders: Such as jaundice (yellowing of the skin) or unusual changes. Delay in motor skills: Difficulty achieving age-appropriate motor milestones.

What is the Neonatal Screening Profile Type 2? It is a test performed on newborns to detect a range of genetic and metabolic disorders early. How is the test performed? A small blood sample is taken from the baby, usually from the heel, and analyzed in the laboratory. How long does it take to get results? Results are typically available within a few days. Does the test require special preparation? Usually, no special preparation is needed, but it is recommended to be done after 24 hours of birth. Is the test painful for the baby? The procedure is simple, and the baby may feel slight discomfort when the blood is drawn. What happens if the results are positive? If results are positive, additional tests will be conducted to confirm the findings and determine the appropriate treatment plan. Can the disorders detected appear after the test? The screening helps in early detection, allowing intervention and treatment before symptoms appear.

Negative results: Indicate that no genetic or metabolic disorders were detected, suggesting the baby is healthy. Positive results: Indicate a potential disorder, requiring further tests for confirmation.

Neonatal Screening Type 2 in KSA | Lahalak Platform

An expanded screening panel for newborns aimed at discovering a wide range of rare genetic and metabolic diseases, providing the highest level of health safety for your baby.

Prices starts from: 132.56 SAR

Scientific name: Neonatal Screening Profile Type 2

The Neonatal Screening Profile type 2 test is a laboratory test performed on newborns to screen for a range of genetic and metabolic disorders that may affect their health. This screening is usually carried out during the first days after birth and aims to detect conditions such as inherited metabolic diseases, which can lead to serious health prob...

Service type Preventive medical screening

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 132.56 SAR

Included Services

Neonatal Screening Profile type 2 Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Metabolic disorders: Such as phenylketonuria (PKU), galactosemia, and amino acid metabolism defects.
Enzyme deficiencies: Including deficiencies of specific enzymes that affect how the body processes nutrients.
Other disorders: May include some rare genetic conditions that can impact a child’s growth and development.

Recommended groups

All newborns: This test is performed as part of routine screening for all newborn babies after birth.
Children with a family history of genetic disorders: It is recommended for children who have relatives with known genetic conditions.
Children born under special medical conditions: Such as babies born with low birth weight or those who underwent blood transfusions.
Children showing abnormal symptoms: Such as poor growth or feeding difficulties.

Symptoms indicative

Growth delay: Failure to gain weight or grow in length normally.
Feeding problems: Difficulty breastfeeding or decreased appetite.
Behavioral changes: Such as lethargy or noticeably low activity.
Breathing difficulties: Such as labored or rapid breathing.
Skin disorders: Such as jaundice (yellowing of the skin) or unusual changes.
Delay in motor skills: Difficulty achieving age-appropriate motor milestones.

FAQs

What is the Neonatal Screening Profile Type 2? It is a test performed on newborns to detect a range of genetic and metabolic disorders early.
How is the test performed? A small blood sample is taken from the baby, usually from the heel, and analyzed in the laboratory.
How long does it take to get results? Results are typically available within a few days.
Does the test require special preparation? Usually, no special preparation is needed, but it is recommended to be done after 24 hours of birth.
Is the test painful for the baby? The procedure is simple, and the baby may feel slight discomfort when the blood is drawn.
What happens if the results are positive? If results are positive, additional tests will be conducted to confirm the findings and determine the appropriate treatment plan.

Normal Levels

Negative results: Indicate that no genetic or metabolic disorders were detected, suggesting the baby is healthy.
Positive results: Indicate a potential disorder, requiring further tests for confirmation.

Conditions & Notices

The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

Neonatal Screening Type 2 in KSA | Lahalak Platform

Included Services

Medical Service Information

Purpose Test

Recommended groups

Symptoms indicative

FAQs

Normal Levels

Conditions & Notices

Medical services you might also like

Check Your Cellular Enzyme Health

Advanced Phenylalanine GC-MS Test

Body Energy & Metabolism Profile

Genetic Muscle Dystrophy Test